EDGEWISE THERAPEUTICS INC's ticker is EWTX and the CUSIP is 28036F105. A total of 91 filers reported holding EDGEWISE THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 2.00 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $34,790,858 | -26.1% | 6,071,703 | 0.0% | 2.57% | -29.3% |
| Q2 2023 | $47,055,698 | +16.2% | 6,071,703 | 0.0% | 3.64% | +36.1% |
| Q1 2023 | $40,498,259 | -25.4% | 6,071,703 | 0.0% | 2.67% | -21.2% |
| Q4 2022 | $54,281,025 | -9.1% | 6,071,703 | 0.0% | 3.39% | +19.0% |
| Q3 2022 | $59,746,000 | +34.3% | 6,071,703 | +8.7% | 2.85% | +30.1% |
| Q2 2022 | $44,474,000 | -17.9% | 5,587,207 | 0.0% | 2.19% | -23.4% |
| Q1 2022 | $54,196,000 | -36.5% | 5,587,207 | 0.0% | 2.86% | -29.3% |
| Q4 2021 | $85,373,000 | -8.0% | 5,587,207 | 0.0% | 4.04% | -15.7% |
| Q3 2021 | $92,748,000 | -22.2% | 5,587,207 | 0.0% | 4.80% | -9.3% |
| Q2 2021 | $119,175,000 | -34.4% | 5,587,207 | 0.0% | 5.29% | -29.5% |
| Q1 2021 | $181,584,000 | – | 5,587,207 | – | 7.50% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| New Leaf Venture Partners, L.L.C. | 1,553,661 | $15,071,000 | 7.43% |
| Cormorant Asset Management, LP | 4,682,874 | $45,424,000 | 3.49% |
| Novo Holdings A/S | 5,587,207 | $54,196,000 | 2.86% |
| Orbimed Advisors | 13,944,680 | $135,263,000 | 2.19% |
| Opaleye Management Inc. | 303,000 | $2,939,000 | 0.91% |
| DAFNA Capital Management LLC | 356,750 | $3,460,000 | 0.90% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 3,933,137 | $38,151,000 | 0.85% |
| EcoR1 Capital, LLC | 2,359,808 | $22,890,000 | 0.72% |
| RA Capital Management | 2,613,623 | $25,352,000 | 0.55% |
| HighVista Strategies LLC | 59,733 | $579,000 | 0.37% |